BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7050501)

  • 21. Re-examination of the ED01 study--technical discussion of the statistical analysis for adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):81-7. PubMed ID: 7184777
    [No Abstract]   [Full Text] [Related]  

  • 22. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study.
    Cohen SM; Ellwein LB
    Toxicol Appl Pharmacol; 1990 Jun; 104(1):79-93. PubMed ID: 2360210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-examination of the ED01 study. Audit of pathology.
    Fundam Appl Toxicol; 1981; 1(1):64-6. PubMed ID: 7184774
    [No Abstract]   [Full Text] [Related]  

  • 24. Logistics of conducting a chronic study with 24,192 mice.
    Johnson CR
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):9-15. PubMed ID: 7365389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonparametric estimation of the survival function when cause of death is uncertain.
    Racine-Poon AH; Hoel DG
    Biometrics; 1984 Dec; 40(4):1151-8. PubMed ID: 6534414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ED01 study: introduction, objectives, and experimental design.
    Cairns T
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):1-7. PubMed ID: 7365374
    [No Abstract]   [Full Text] [Related]  

  • 27. Cause-of-death assignment at the National Center for Toxicological Research.
    Kodell RL; Blackwell BN; Bucci TJ; Greenman DL
    Toxicol Pathol; 1995; 23(3):241-7. PubMed ID: 7659948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumors of the soft tissues and internal organs in neptunium-237-induced lesions].
    Levdik TI; Buldakov LA
    Vopr Onkol; 1975; 21(1):80-7. PubMed ID: 1090087
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of dose and time in a long-term, low-dose carcinogenic study.
    Littlefield NA; Farmer JH; Gaylor DW; Sheldon WG
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):17-34. PubMed ID: 7365379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The leukemogenic action of phorbol.
    Berenblum I; Lonai V
    Cancer Res; 1970 Nov; 30(11):2744-8. PubMed ID: 4922468
    [No Abstract]   [Full Text] [Related]  

  • 31. Absence of uniform progressive growth of long-term transplants of rat liver neoplastic nodules.
    Ohmori T; Watanabe K; Williams GM
    J Natl Cancer Inst; 1980 Aug; 65(2):485-90. PubMed ID: 6931264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylhydrazine tumorigenesis in Syrian golden hamsters and the morphology of malignant histiocytomas.
    Toth B; Shimizu H
    Cancer Res; 1973 Nov; 33(11):2744-53. PubMed ID: 4355982
    [No Abstract]   [Full Text] [Related]  

  • 33. Biologic and morphologic characteristics of urinary bladder neoplasms induced in BALB/c female mice with 2-acetylaminofluorene.
    Frith CH; Farmer JH; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):103-19. PubMed ID: 7365375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous lesions in control BALB/C female mice.
    Sheldon WG; Greenman DL
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):155-67. PubMed ID: 7365377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological classification of mouse liver tumors based on biological characteristics.
    Becker FF
    Cancer Res; 1982 Oct; 42(10):3918-23. PubMed ID: 7104991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling time-to-tumor data: analysis of the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):458-69. PubMed ID: 6642103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid activity during hepatocarcinogenesis by N-2-fluorenylacetamide in the male rat.
    Aussel C; Lafaurie M; Castelli D; Formento JL; Stora C
    Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):105-17. PubMed ID: 7079578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological model of ED01 hepatocarcinogenesis.
    Travis CC; Zeng C; Nicholas J
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):19-29. PubMed ID: 8806866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-examination of the ED01 study. Review of statistics: the need for realistic statistical models for risk assessment.
    Fundam Appl Toxicol; 1981; 1(1):124-6. PubMed ID: 7184771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.